Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Skin changes can indicate starvation and nutritional deficiencies in anorexia nervosa.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Deregulation of stem cell function is central to the development of some cancers.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Bariatric surgery is safe and effective for treating adolescent obesity.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Obesity is linked to many gastrointestinal diseases and needs more research for treatment development.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

PCOS in teen girls should be managed with lifestyle changes and sometimes medication to improve symptoms and health.